Answers are grounded in this paper and cite their sources.
Air pollution is a well-known risk factor for both pulmonary disorders and neurodegenerative diseases, including Alzheimer’s disease (AD) and related dementia, yet the causal pathways along the lung-brain axis linking airborne exposures, pulmonary disorders, and AD pathology remain poorly understood, hampering the development of effective preventions and interventions for typical sporadic AD. Mendelian randomization (MR) analyses - including univariable, bidirectional, and multivariable MR (MVMR) with formal two-step mediation analysis - leveraging summary statistics from 28 GWAS were used to assess the causal networks along the lung-brain axis. These MR-based analyses captured reciprocal molecular associations, tested via bidirectional MR, among air pollutants (PM2.5, PM10, NO2, NOx), pulmonary disorders, inflammatory and blood-brain barrier (BBB) injury markers (IL-6, IL-17A, MMP-9, VEGF, GFAP), and lowered soluble LRP1 that mediates clearance of pathological amyloid-β (Aβ). MR-based analyses evaluate how air pollution causally increased the risk of inflammation and pulmonary diseases (asthma, emphysema/COPD, pulmonary fibrosis, and lung cancer), lung function impairment (FEV1, FVC, FEV1/FVC), and elevated AD risk. In turn, pulmonary disorders can lower expression of soluble LRP1. Bidirectional MR-based causal analyses indicate that air pollution-driven pulmonary diseases (e.g. emphysema/COPD ) causally lowered expression of soluble LRP1, and reduced LRP1 was reciprocally associated with elevated inflammatory markers (IL-6→LRP1, p = 1.13 × 10 − 15 ) and vascular/BBB injury markers (MMP-9→LRP1, p = 9.96 × 10 − 14 ), forming an interconnected network along the lung-brain axis. Formal two-step mediation analysis further indicated that MMP-9 significantly mediates part of the causal pathway from emphysema to reduced soluble LRP1. Reciprocally, reduced LRP1 aggravated inflammation (IL-6, p = 6.73 × 10 − 6 ) and BBB injury (MMP-9, p = 7.51 × 10 − 8 ), which in turn, caused/aggravated emphysema/COPD (or pulmonary fibrosis) and further reduced LRP1 levels thereby forming an air pollution-triggered/reinforced vicious cycle of pulmonary diseases and BBB disruption and reduced LRP1, a central molecular node in Aβ-induced AD pathology. Additionally, air pollutants were associated with reduced FEV1 and elevated AD risk. Moreover, FEV1 reduction, MMP-9 elevation, and LRP1 reduction formed an interconnected network of associations along the lung-brain axis, consistent with a potential pathway linking pulmonary dysfunction, systemic inflammation, and BBB-related receptor dysregulation to AD risk. MR-based causal analysis of the lung-brain axis indicated chronic air pollution is associated with pulmonary disorders, neuroinflammation, vascular injury/BBB leakage, and dysregulation of LRP1. Moreover, causal analysis indicated dysregulated soluble LRP1 and chronic air pollution can disrupt MMP-9 and BBB integrity, and aggravate neuroinflammation via dysregulation of IL-6/IL-17A, and in turn, can cause pulmonary disorders thereby forming a vicious cycle along the lung-brain axis further reinforced by chronic exposure to air pollutants. The newly evaluated causal network provides opportunities for developing novel prevention and intervention measures for AD which currently has neither a cure nor treatments to effectively halt disease progression broadly.
No takes yet. Share an insight, caveat, or question.
Ashebir et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: